Flortaucipir
- Generic Name
- Flortaucipir
- Drug Type
- Small Molecule
- Chemical Formula
- C16H10FN3
- CAS Number
- 1415379-56-4
- Unique Ingredient Identifier
- J09QS3Z3WB
- Background
Flortaucipir is under investigation in clinical trial NCT03507257 (Longitudinal Early-onset Alzheimer's Disease Study Protocol).
NFL LONG Prospective Study
- Conditions
- Concussion, Brain
- Interventions
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 250
- Registration Number
- NCT04263337
- Locations
- 🇺🇸
Boston Children's Hospital, Waltham, Massachusetts, United States
🇺🇸University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- Conditions
- Early Onset Alzheimer DiseaseAlzheimer DiseaseMild Cognitive Impairment
- Interventions
- First Posted Date
- 2018-04-25
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 850
- Registration Number
- NCT03507257
- Locations
- 🇺🇸
Banner Sun Health Research Institute, Sun City, Arizona, United States
🇺🇸University of California, Los Angeles, Los Angeles, California, United States
🇺🇸Stanford University, Palo Alto, California, United States
Alzheimer's Disease Neuroimaging Initiative 2
- Conditions
- Alzheimer's Disease (AD)Early Mild Cognitive Impairment (EMCI)Mild Cognitive Impairment (MCI)Significant Memory Concern (SMC)Late Mild Cognitive Impairment (LMCI)
- Interventions
- Drug: Florbetapir
- First Posted Date
- 2010-11-01
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 1182
- Registration Number
- NCT01231971
- Locations
- 🇺🇸
University of Alabama, Birmingham, Birmingham, Alabama, United States
🇺🇸Banner Alzheimer's Institute, Phoenix, Arizona, United States
🇺🇸Banner Sun Health Research Institute, Sun City, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.